Successful Deep Inferior Epigastric Perforator Flap Harvest despite Preoperative Therapeutic Subcutaneous Heparin Administration into the Abdominal Pannus

Table 1

Table of clinical data.

Patient	1	2	3
Age (years)	55	33	37
BMI (kg/m^2)	25	40	29
Tumour Grade	III	III	II
Receptor status	ER+/HER2−	ER-/HER2−	ER+/HER2+
Reason for anticoagulation	Axillary vein thrombosis	History of port-related thrombosis	Subclavian vein thrombosis
Time to thrombus	6 weeks	NA	4 weeks
Enoxaparin dose (mg)	100	40	80
Duration of anticoagulation	3 months	2 months	4 months
Time LMWH stopped preoperatively (hours)	32 h	24 h (10 mg, 2 weeks earlier)	32 h
Operation side	Unilateral	Bilateral	Unilateral
Lymph node surgery	Level II ANC	Level II ANC	SLNBx
Flap weight (grams)	662 g	794 g (L), 805 g (R)	690 g
Perforators	Lateral row ×4	Medial row ×1 (L), lateral row ×2 (R)	Medial row ×1
Ischaemia time (mins)	97	79 (L), 80 (R)	26
EBL from swab weights (mL)	800	719	560
Thromboprophylaxis	40 mg enoxaparin	5000 units of dalteparin	5000 units of dalteparin
Total drain output (litres)	2.7 L	1.2 L	1.2 L
Hospital stay	7 days	7 days	6 days

EBL: estimated blood loss.
NA: not applicable.
ANC: axillary node clearance.
SLNBx: sentinel lymph node biopsy.